| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |